Enzo Life Sciences is pleased to unveil our newest immunohistochemistry product, MULTIVIEW® PLUS (mouse-HRP/rabbit-AP) IHC Kit (Brown/Green). This non-biotin nanopolymer detection system contains reagents and materials that detect and localize antigens in formalin-fixed paraffin-embedded tissues. The new MULTIVIEW PLUS IHC kit optimizes your IHC process by including the entire workflow, from antigen retrieval to visualization.
The MULTIVIEW PLUS system can detect multiple antigens on a single tissue sample, while eliminating the traditional two-step method using biotin/avidin conjugates. Our high sensitivity, low background reagents are made using our proprietary labeling technology and consist of nanopolymers conjugated to horseradish peroxidase (HRP) and alkaline phosphatase (AP), yielding superior multiplex detection results.
Included in the kit are MULTIVIEW PLUS HRP (Anti-Mouse) Reagent and MULTIVIEW PLUS AP (Anti-Rabbit) Reagent, which have been developed by labeling anti-mouse and anti-rabbit immunoglobulins. Use of our labeling technology helps deliver consistent and reproducible results across a wide range of tissue and cell types. The kit also includes our HIGHDEF® Chromogens which deliver sharp, crisp images with high specificity.
Our MULTIVIEW PLUS kit is the latest product in Enzo’s comprehensive list of highly reliable IHC kits and reagents. With our high definition chromogens, worry-free antibodies, and more, you can depend on Enzo to enhance your immunohistochemistry experience.
About Enzo Life Sciences
Enzo Life Sciences, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York. Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and therapeutics through the development of unique diagnostic platform technologies. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products and services that meet the ever-changing and rapidly growing needs of healthcare. Underpinning Enzo Biochem’s technologies, platforms and products is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.
Enzo Life Sciences, Inc. is a pioneer in labeling and detection technologies from genome to whole cell across research and diagnostic markets. We are focused on providing cost-effective, relevant and reliable solutions for life science research, drug development, and clinical research. We are organized to lead in the development, production, marketing, and sales of innovative research tools worldwide based on 40 years’ experience in building strong global market recognition and implementing outstanding operational capabilities.
New Product Release
Date: April 11th 2017
For additional Information, please contact:
Kara Cannon, Global Head of Marketing
1-631-694-7070 x 1301